ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2025
GDF15 and history of pregnancy-induced nausea as predictors of treatment-induced nausea severity in women following surgery for early-stage breast cancer.
Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Letter to the editor: GDF15 and history of pregnancy-induced nausea as predictors of treatment-induced nausea severity in women following surgery for early-stage breast cancer.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025Article
Corrections and comments
- Commented on by
Authors and funding
9 authors.
Funding
Abstract
purposeTreatment-induced nausea (TIN) is a persistent and distressing symptom among women undergoing breast cancer therapy, despite adherence to antiemetic guidelines. A history of pregnancy-induced nausea and vomiting (PNV) and genetic variations in GDF15, a stress-responsive cytokine, may contribute to nausea susceptibility. The purpose of this study was to understand the relationship between GDF15 variants, history of PNV, and the prediction of TIN severity across the first 6 months following breast cancer surgery.
methodsA prospective, 6-month longitudinal cohort study enrolled 290 women undergoing surgery for early-stage breast cancer. Nausea severity was assessed using a 0-10 numeric rating scale at multiple time points post-surgery and during adjuvant therapy. Saliva samples were genotyped for GDF15 single nucleotide polymorphisms (SNPs) (rs810804, rs1227731, rs8101249, rs1059369). Group-based trajectory modeling (GBTM) identified nausea severity patterns. Associations between GDF15 SNPs, PNV history, and TIN severity were analyzed using multivariate logistic regression.
resultsThree nausea severity trajectories were identified: extremely low (41%), low (47%), and moderate (12%). A history of PNV significantly predicted higher TIN severity (p < 0.05). Additionally, GDF15 SNPs rs8101249 and rs1227731 were associated with TIN severity trajectories. In the final multivariate model, PNV history and rs1227731 remained significant predictors.
conclusionsPNV history and GDF15 genetic variants influence TIN severity in women undergoing breast cancer treatment. Identifying at-risk patients may improve symptom management. Future research should explore GDF15-targeted interventions to reduce nausea burden.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.